Thus, these results indicate that Cx26 is incapable of forming functional GJIC between NSCLC cells due to the defects in plasma membrane assembly, excluding the possible involvement of GJIC in the Cx26-mediated EMT and acquired gefitinib resistance in NSCLC cells. Here, GJB2 is linked to non-small cell lung carcinoma.